Insulin-like growth factor-I induces the phosphorylation and nuclear exclusion of forkhead transcription factors in

T S Schwab1, B B Madison, A R Grauman

  • 1Department of Neurology, University of Michigan, 4414 Kresge III, 200 Zina Pitcher Place, Ann Arbor, MI 48109, USA.

Insights

Insulin-like growth factor-I (IGF-I) promotes neuroblastoma cell survival by phosphorylating forkhead proteins FKHR and FKHRL1. This process, dependent on PI3-K signaling, regulates their cytoplasmic localization, preventing apoptosis.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Neuroscience

Background:

  • Akt-mediated phosphorylation of forkhead transcription factors is a known mechanism for growth factor-stimulated cell survival.
  • The role of this pathway in neuroblastoma cell survival, particularly concerning insulin-like growth factor-I (IGF-I), requires further investigation.

Purpose of the Study:

  • To investigate the association between IGF-I survival activity in SH-SY5Y human neuroblastoma cells and the phosphorylation and localization of forkhead proteins.
  • To elucidate the specific signaling pathways involved in IGF-I-mediated regulation of forkhead transcription factors.

Main Methods:

  • Utilized SH-SY5Y human neuroblastoma cells.
  • Stimulated cells with IGF-I and employed PI3-K inhibitor LY294002 and Crm1 inhibitor Leptomycin B.
  • Assessed phosphorylation of FKHR, FKHRL1, Akt, and Erks using Western blotting.
  • Tracked localization of GFP-FKHR fusion protein via microscopy.

Main Results:

  • IGF-I induced phosphorylation of FKHR (at Ser 253), FKHRL1 (at Ser 256), Akt (at Ser 473), and Erks.
  • PI3-K inhibition blocked IGF-I-stimulated phosphorylation of FKHR, FKHRL1, and Akt, but not Erks.
  • IGF-I promoted nuclear export of GFP-FKHR during serum withdrawal-induced apoptosis rescue.
  • Leptomycin B inhibited FKHRL1 phosphorylation and GFP-FKHR nuclear export in the presence of IGF-I.

Conclusions:

  • IGF-I promotes survival of neuroblastoma cells by phosphorylating FKHR and FKHRL1 through a PI3-K-dependent pathway.
  • This phosphorylation event is linked to the cytoplasmic localization of these transcription factors, preventing their nuclear import and subsequent apoptosis.
  • The findings highlight a critical signaling axis for neuroblastoma cell survival regulated by IGF-I.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...